MedTrace Logo

Indomethacin Eyedrops Compared With Ketorolac Eyedrops for Ocular Inflammation Following Cataract Surgery

NCT00904904 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2012-08-13

No results posted yet for this study

Summary

This study is being conducted to show that indomethacin is at least as effective as ketorolac for the prevention of ocular inflammation following cataract surgery.

Conditions

Interventions

DRUG

Indomethacin ophthalmic solution

Indomethacin 0.1% eye drops administered pre-cataract surgery and for 4 weeks post-cataract surgery

DRUG

Ketorolac Ophthalmic Solution

Ketorolac 0.5% eye drops administered pre-cataract surgery and 4 weeks post-cataract surgery

Sponsors & Collaborators

  • Bausch & Lomb Incorporated

    lead INDUSTRY

Principal Investigators

  • Gabriele Brenger · Bausch & Lomb Incorporated

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-04-30
Primary Completion
2009-06-30
Completion
2009-09-30

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00904904 on ClinicalTrials.gov